[ad_1]
The National Institute for Food and Drug Monitoring, Invima indicated, following a statement, that following the international identification of a carcinogenic substance the valsartan a drug used by patients hypertension it was removed from the national market
"The NDMA substance was clbadified as probably carcinogenic by the International Agency for Research on Cancer (IARC) and its presence is shown in tobacco smoke, some processed foods and some toiletries, "says document.
Given this scenario, the entity has stated that and the holders of the sanitary registration of the laboratories: American Generics SAS, Genfar SA, Humax Pharmaceutical SA ., Laboratoire Franco Colombiano Lafrancol SAS, MK Laboratories SAS, Lafrancol Internacional SA S, Procaps SA, Sanofi-Aventis and Colombia S.A., Tecnoquímicas S.A., Winthrop Pharmaceuticals of Colombia S.A. has determined as a preventive measure the voluntary withdrawal from the market of its medicinal products containing this drug.
[ad_2]
Source link
